ASX-Dividend-Report-Banner

Neuragenex Brings Innovative Fibromyalgia Treatment to Patients Across the US

October 26, 2023 02:23 AM AEDT | By Cision
Follow us on Google News: https://kalkinemedia.com/resources/assets/public/images/google-news.webp
 Neuragenex Brings Innovative Fibromyalgia Treatment to Patients Across the US
Image source: Kalkine Media

GULBERT, Ariz., Oct. 25, 2023 /PRNewswire/ -- Neuragenex, the national healthcare provider focused on non-pharmaceutical pain treatment, announced its continued expansion to bring relief to fibromyalgia patients across the country.

With clinics now operating in Georgia, Texas, Illinois, Tennessee and Utah, Neuragenex aims to ease the suffering of the nearly 4 million Americans from all walks of life afflicted by fibromyalgia in its various forms.

Most misunderstood disease

Fibromyalgia is a complex, frequently misunderstood condition characterized by widespread muscle pain and tenderness, chronic fatigue, sleep disturbances and other debilitating symptoms. Patients often struggle for years to get an accurate diagnosis, shuffling between doctors while their quality of life deteriorates.

Too often, the only solutions offered are heavy pharmaceutical regimens that mask symptoms without addressing underlying dysfunctions. Neuragenex takes a different approach. Through their proprietary Neurofunctional Pain Management protocol, Neuragenex clinicians identify and treat the root physiological factors that contribute to fibromyalgia pain and dysfunction.

A better solution

The Neuragenex approach enables the body's natural pain relief and regulation mechanisms to reactivate, with patients reporting an average 90% reduction in pain and associated symptoms. "Most doctors don't have an effective way to handle fibromyalgia, yet they understand the real pain their patients endure." said Neuragenex CEO Will Bozeman.

Neuragenex welcomes inquiries from medical professionals interested in referring patients to their clinics at the company's website. CEO Will Bozeman added "When confronted with this difficult and misunderstood condition, it becomes all too easy to simply prescribe medications. We want providers nationwide to know there's a better solution. Neurofunctional Pain Management protocol offers a much-needed non-pharmaceutical treatment option for fibromyalgia with excellent patient outcomes."

With continued expansion planned, Neuragenex aims to bring life-changing relief to thousands more fibromyalgia sufferers across the nation. For more information about Fibromyalgia treatment solutions or about Neuragenex and its new clinic locations, please visit the company website at www.neuragenex.com.

About Neuragenex

Neuragenex is a pioneering company dedicated to revolutionizing pain management. With an approach that focuses on electroanalgesia, Neuragenex's treatments have been designed to provide relief and improve the lives of individuals suffering from chronic pain without drugs or surgery. Committed to pushing the boundaries of pain management, Neuragenex continuously aims to provide relief and improve the lives of individuals suffering from persistent pain.B

Media contact

Will Bozeman
Email: [email protected]


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.

Recent Articles

Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.